New study aims to find best Pre-Surgery hormone treatment for men with breast cancer

NCT ID NCT05501704

Recruiting now Disease control Sponsor: Jose Pablo Leone Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests different hormone therapies in men with breast cancer before they have surgery. The goal is to see which treatment works best to shrink the tumor. About 60 men with hormone receptor-positive breast cancer will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

estrogen-receptor negative breast cancer Her2-receptor negative breast cancer hormone receptor-positive breast cancer male breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA HORMONE RECEPTOR POSITIVE BREAST CANCER MALE BREAST CANCER

Contacts and locations

Locations

Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02115, United States
Georgetown University Medical Center
RECRUITING

Washington D.C., District of Columbia, 20007, United States
M. D. Anderson Cancer Center at University of Texas
RECRUITING

Houston, Texas, 77030-4009, United States
Mayo Clinic
RECRUITING

Rochester, Minnesota, 55905, United States
UNC Lineberger Comprehensive Cancer Center
RECRUITING

Chapel Hill, North Carolina, 27599, United States
University of Pennsylvania, Abramson Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh Cancer Institute
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States
Vanderbilt Cancer Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.